Krakow, Poland – March 16, 2021 – Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, won the third-place award in the category “Products and services Innovation” in the Stock Exchange Company of the Year competition organized by “Puls Biznesu” – one of the largest business daily in Poland.

It was the 22nd edition of the competition, the oldest and the most prestigious ranking in the Polish capital market. Every year 100 professionals choose the best company. The jury consists of market analysts, investment advisers and managers, institutional investors, and securities house representatives. These experts measure companies in five categories: the management board competencies, success, products and services innovation, investor relations, and development perspectives.